CytRx has lower revenue, but higher earnings than Momenta Pharmaceuticals. Momenta Pharmaceuticals is trading at a lower price-to-earnings ratio than CytRx, indicating that it is currently the more …
More Critical Review: Momenta Pharmaceuticals (NASDAQ:MNTA) & CytRx (NASDAQ:CYTR) Videos